🇺🇸 SODIUM CHROMATE CR 51 in United States

FDA authorised SODIUM CHROMATE CR 51 on 27 December 1971

Marketing authorisations

FDA — authorised 27 December 1971

  • Application: NDA013993
  • Marketing authorisation holder: BRACCO
  • Local brand name: CHROMITOPE SODIUM
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

SODIUM CHROMATE CR 51 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SODIUM CHROMATE CR 51 approved in United States?

Yes. FDA authorised it on 27 December 1971; FDA has authorised it.

Who is the marketing authorisation holder for SODIUM CHROMATE CR 51 in United States?

BRACCO holds the US marketing authorisation.